Welcome to the new ASOP EU website
ASOP EU is a loose coalition of patient groups, companies, organisations and individuals, united in the campaign to make the internet a safer place to obtain medicines (where it is legal to do so).
Within these pages, we hope that you will find everything that you need to help you stay safe online. If you have any questions that aren't answered here, you can ask our experts using the link above.
Falsified Medicine is a scary subject. It unites the otherwise polarised worlds of organised crime and healthcare. However, it can also pose everyday challenges. Why not click "Spotting a Fake" above, to find out just how good a detective you would make?
From all of us at ASOP EU, we hope you enjoy navigating through the website.
Stay safe online!
My medicine seems much cheaper online. The website says that it can do this because the pills come from India. Why can't my pharmacy offer that as well?
The chances are that the "Indian" medicine is not licensed for use in your country. In Europe, medicines are strictly licensed and regulated, to protect you and your health. You know how it is produced, stored and dispensed. Stay safe!
I pay for my medicine and bulk-buying seems like a great deal! Is it?
In Europe, it is illegal to offer bulk discounts on prescription medicines. If your online "pharmacy" is breaking that law, the chances are it won't stop there. Check our advice on how to stay safe online.
I am afraid to go to the doctor because I don't think he would prescribe the medicine that I think I need. Why shouldn't I just go online, it's so discreet?
Obviously we can't know what your medical condition is but you should be aware that many quite serious illnesses can go undiagnosed (and therefore untreated) if you self-medicate to treat just the symptoms. For example, erectile problems are known to be an early indicator of cardiovascular disease and Diabetes. Your doctor is the person best placed to advise and, together with you, decide on the best treatment for you. The last thing you need to be is afraid.
MOUNT PROSPECT, Ill.
Counterfeit pharmaceuticals remain one of the world’s fastest growing industries.
The European Commission has introduced a logo for legitimate online pharmacies that aims to prevent...
ASOP EU News
11 Aug 2014
On July 17, 2014, ASOP, ASOP EU and CSIP hosted a seminar on “Protecting Patients from Falsified Medicines Online” on the margins of the Transatlantic Intellectual Property Rights Working Group meeting held in Brussels, Belgium.
Citizens in the US and EU Member States are the world’s primary targets for illegal online drug sellers, where approximately 30,000 – 50,000 illegal online pharmacies are active at any one time and 97% are out of compliance with applicable laws and standards. The seminar emphasized this growing, transatlantic threat of rogue online pharmacies preying on consumers in the United States and European Union.
ASOP EU highlights the need for greater collaboration at the EFPIA Health & Growth meeting Lyon 4-6 June 2014
16 Jun 2014
Mike Isles Executive director addressed the issues of the rising crime of illegal online rogue medicine sellers at the recently held pan European meeting convened by EFPIA – the European Federation of Pharmaceutical Industries and Associations at the Lyon Congress centre. Highlighting recent consumer research he made it clear that the public needed to be better informed. The activities of ASOP EU will certainly help this but it will require global, regional and local initiatives to raise the level of awareness to an effective level.
15 May 2014
Paris, France - Committed to the fight against counterfeiting for many years, Sanofi now reveals how Europeans perceive counterfeit drugs through a survey of 5,010 people in France, Germany, Italy, Spain and the United Kingdom. "The general public is not sufficiently informed about the existence of counterfeit drugs and the risks it may be taking in certain purchasing situations. Counterfeit medicines are a real danger to patients' health. For example, they may not contain the same amount of active ingredient as the genuine drug or not meet the same requirements in terms of quality, efficiency and safety as the genuine treatments", said Dr Caroline Atlani, anti-counterfeiting coordination director at Sanofi.